Evidence map›Paper›PMID 36534410›Full record

ArticleAnalytical chemistry2023

Highly Accurate and Robust Absolute Quantification of Target Proteins in Formalin-Fixed Paraffin-Embedded (FFPE) Tissues by LC-MS.

Jie Pu, Chao Xue, Shihan Huo, Qingqing Shen, Yang Qu, Xinxin Yang, Bo An, Thomas E Angel, Zhuo Chen, John T Mehl and 4 more

Open access · greenAbstract read
In one paragraph

Article in Analytical chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Jie PuDepartment of Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, New York 14214, United States.
Chao XueDepartment of Chemical and Biological Engineering, University at Buffalo, State University of New York, Buffalo, New York 14214, United States.
Shihan HuoDepartment of Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, New York 14214, United States.
Qingqing ShenDepartment of Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, New York 14214, United States.
Yang QuDepartment of Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, New York 14214, United States.
Xinxin YangDepartment of Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, New York 14214, United States.
Bo AnBioanalysis, Immunogenicity & Biomarkers, In-Vitro/In-Vivo Translation, R&D Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States.
Thomas E AngelBioanalysis, Immunogenicity & Biomarkers, In-Vitro/In-Vivo Translation, R&D Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States.ORCID 0000-0002-1601-3151
Zhuo ChenBioanalysis, Immunogenicity & Biomarkers, In-Vitro/In-Vivo Translation, R&D Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States.
John T MehlBioanalysis, Immunogenicity & Biomarkers, In-Vitro/In-Vivo Translation, R&D Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States.
Huaping TangBioanalysis, Immunogenicity & Biomarkers, In-Vitro/In-Vivo Translation, R&D Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States.
Eric YangBioanalysis, Immunogenicity & Biomarkers, In-Vitro/In-Vivo Translation, R&D Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States.
Timothy W SikorskiBioanalysis, Immunogenicity & Biomarkers, In-Vitro/In-Vivo Translation, R&D Research, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States.
Jun QuDepartment of Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, New York 14214, United States.ORCID 0000-0002-1346-6809
GlaxoSmithKline (United States) · USUniversity at Buffalo, State University of New York · US

Funding

Systems Biology of GlycosylationR01HL103411 · NHLBI · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI NEELAMEGHAM, SRIRAM · 2011 to 2025
$7.1M
Modeling Mechanisms of Adjuvanted Influenza Vaccine Induced IgG Repertoire Diversity and Heterosubtypic ImmunityR01AI129518 · NIAID · UNIVERSITY OF ROCHESTER · PI HYRIEN, OLLIVIER, ZAND, MARTIN S · 2017 to 2021
$3.5M
Multiplex Mass Spectrometric Protein Assays for Precise Monitoring of the Pathophysiology of ObesityU01DK124020 · NIDDK · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI QIAN, WEI-JUN · 2019 to 2022
$3.3M
NHLBI NIH HHS R01 HL103411NIAID NIH HHS R01 AI129518NIDDK NIH HHS U01 DK124020
6 · The paper itself

Abstract

Accurate, absolute liquid chromatography-mass spectrometry (LC-MS)-based quantification of target proteins in formalin-fixed paraffin-embedded (FFPE) tissues would greatly expand sample availability for pharmaceutical/clinical investigations but remains challenging owing to the following issues: (i) efficient/quantitative recovery of target signature peptides from FFPE tissues is essential but an optimal procedure for targeted, absolute quantification is lacking; (ii) most FFPE samples are long-term-stored; severe immunohistochemistry (IHC) signal losses of target proteins during storage were widely reported, while the effect of storage on LC-MS-based methods was unknown; and (iii) the proper strategy to prepare calibration/quality-control samples to ensure accurate targeted protein analysis in FFPE tissues remained elusive. Using targeted quantification of monoclonal antibody (mAb), antigen, and 40 tissue markers in FFPE tissues as a model system, we extensively investigate those issues and develope an LC-MS-based strategy enabling accurate and precise targeted protein quantification in FFPE samples. First, we demonstrated a surfactant cocktail-based procedure (

Indexed as

PeptidesTandem Mass SpectrometryAntibodies, MonoclonalChromatography, LiquidFormaldehydeParaffin EmbeddingTissue FixationAntibodies, MonoclonalFormaldehydePeptides

Identifiers

PMID36534410
PMCPMC10581745
OpenAlexW4311934341

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.